Emily Hinchcliff, MD, MPH
Dr. Emily Hinchcliff is an Assistant Professor of Gynecologic Oncology at Northwestern Medicine. Dr. Hinchcliff is skilled surgeon who believes in working closely with her patients in order to deliver comprehensive and personalized care. She provides both surgical management and chemotherapy to women with gynecologic cancers. Her areas of surgical expertise include minimally invasive surgery for both endometrial and ovarian cancer, as well as for complex benign gynecologic conditions. She additionally performs complex pelvic and abdominal surgeries, including radical debulking surgery for advanced ovarian cancer, radical hysterectomy for cervical cancer, and radical trachelectomy for young women with cervical cancer who desire future fertility.
Dr. Hinchcliff is also passionate about improving outcomes for women with advanced or recurrent cancer, with a focus on developing novel or targeted therapeutic options. Her background in public health, centering on clinical investigation, has allowed her to design innovative clinical trials to benefit these women. An avid researcher, Dr. Hinchcliff has particular interest in the role of immunotherapy in gynecologic cancer treatment and has received funding to pursue research in this area. She has published multiple peer-reviewed manuscripts in high impact journals, co-authored book chapters, and has presented her work at national meetings. She serves on national committees including being appointed to the New Investigators Committee of NRG Oncology for clinical trialists across specialties, and has served on the Society for Gynecologic Oncology Education and Program Committees. She is the recipient of several awards for both her clinical and research contributions.
Dr. Hinchcliff received her medical degree from Harvard Medical School, where she stayed to complete her residency training at the Brigham and Women’s Hospital/Massachusetts General Hospital Integrated Residency program in Obstetrics and Gynecology. She then completed a fellowship in Gynecologic Oncology at the University of Texas MD Anderson Cancer Center. She also received her Masters in Public Health from the University of Texas School of Public Health, with a concentration in clinical trial design and epidemiology. Throughout her training, she has received numerous accolades and awards for her excellence in clinical care, compassion, skills as an educator, and her leadership.